Transplantation-Induced Ischemia-Reperfusion Injury Modulates Antigen Presentation by Donor Renal CD11c+F4/80+ Macrophages through IL-1R8 Regulation

Sistiana Aiello(Mario Negri Institute for Pharmacological Research), Manuel Alfredo Podestà(Mario Negri Institute for Pharmacological Research), Pamela Y. Rodriguez-Ordonez(Mario Negri Institute for Pharmacological Research), Francesca Pezzuto(Mario Negri Institute for Pharmacological Research), Nadia Azzollini(Mario Negri Institute for Pharmacological Research), Samantha Solini(Mario Negri Institute for Pharmacological Research), Camillo Carrara(Mario Negri Institute for Pharmacological Research), Marta Todeschini(Mario Negri Institute for Pharmacological Research), Federica Casiraghi(Mario Negri Institute for Pharmacological Research), Marina Noris(Mario Negri Institute for Pharmacological Research), Giuseppe Remuzzi(University of Milan), Ariela Benigni(Mario Negri Institute for Pharmacological Research)
Journal of the American Society of Nephrology
January 27, 2020
Cited by 52Open Access
Full Text

Abstract

Significance Statement Renal macrophages are key cells in controlling processes related to inflammation or repair after ischemia-reperfusion injury. Although macrophages from a donor kidney could also guide adaptive immune responses against renal tissue by virtue of their ability to act as antigen-presenting cells, data are lacking on whether donor-derived renal macrophages can function in this manner after being subjected to transplant-induced ischemia-reperfusion injury. The authors demonstrate in mice that such injury is sufficient to dampen donor renal macrophages’ ability to present antigens, skewing them toward a proreparative phenotype. Donor renal macrophages lacking IL-1R8 failed to orchestrate tissue repair, indicating that IL-1R8 is a key regulator of this shift. IL-1R8 thus represents a pathway that merits exploration in terms of modulating responses against autoantigens and alloantigens after kidney transplant. Background In donor kidneys subjected to ischemia-reperfusion injury during kidney transplant, phagocytes coexpressing the F4/80 and CD11c molecules mediate proinflammatory responses and trigger adaptive immunity in transplantation through antigen presentation. After injury, however, resident renal macrophages coexpressing these surface markers acquire a proreparative phenotype, which is pivotal in controlling inflammation and fibrosis. No data are currently available regarding the effects of transplant-induced ischemia-reperfusion injury on the ability of donor-derived resident renal macrophages to act as professional antigen-presenting cells. Methods We evaluated the phenotype and function of intragraft CD11c + F4/80 + renal macrophages after cold ischemia. We also assessed the modifications of donor renal macrophages after reversible ischemia-reperfusion injury in a mouse model of congeneic renal transplantation. To investigate the role played by IL-1R8, we conducted in vitro and in vivo studies comparing cells and grafts from wild-type and IL-R8–deficient donors. Results Cold ischemia and reversible ischemia-reperfusion injury dampened antigen presentation by renal macrophages, skewed their polarization toward the M 2 phenotype, and increased surface expression of IL-1R8, diminishing activation mediated by toll-like receptor 4. Ischemic IL-1R8–deficient donor renal macrophages acquired an M 1 phenotype, effectively induced IFN γ and IL-17 responses, and failed to orchestrate tissue repair, resulting in severe graft fibrosis and aberrant humoral immune responses. Conclusions IL-1R8 is a key regulator of donor renal macrophage functions after ischemia-reperfusion injury, crucial to guiding the phenotype and antigen-presenting role of these cells. It may therefore represent an intriguing pathway to explore with respect to modulating responses against autoantigens and alloantigens after kidney transplant.


Related Papers

No related papers found

Powered by citation graph analysis